Challenges of conducting clinical trials of natural products to combat cancer

Clinical Advances in Hematology and Oncology

Volumn 14, Issue 6, 2016, Pages 447-455

  Paller, Channing J ^a   Denmeade, Samuel R ^a   Carducci, Michael A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cancer; Clinical trials; Dietary supplements; Natural products; Patents

Indexed keywords

ASCORBIC ACID; NATURAL PRODUCT; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT;

ARTICLE; BIOAVAILABILITY; DIET SUPPLEMENTATION; DRUG APPROVAL; FINANCIAL DEFICIT; FOOD AND DRUG ADMINISTRATION; FOOD PROCESSING; HEALTH CARE POLICY; HUMAN; OVERALL SURVIVAL; PATIENT SAFETY; PHARMACOKINETICS; PHASE 3 CLINICAL TRIAL (TOPIC); POMEGRANATE; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; QUALITY OF LIFE; THERAPY EFFECT; VEGETABLE; BIOASSAY; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; METHODOLOGY; NEOPLASMS; PATENT; TREATMENT OUTCOME; UNITED STATES;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DRUG APPROVAL; ENDPOINT DETERMINATION; HUMANS; NEOPLASMS; PATENTS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84975679528     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hartwell JL. Plants Used Against Cancer. Lawrence, MA: Quarterman; 1981.
2. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3): 311-335.
3. Marty M, Extra JM, Espie M, Leandri S, Besenval M, Krikorian A. Advances in vinca-alkaloids: navelbine. Nouv Rev Fr Hematol. 1989;31(2): 77-84.
4. Khayat D, Antoine E. Docetaxel in combination chemotherapy for metastatic breast cancer. Sem Oncol. 1997;24(4 suppl 13): S13-19-S13-26.
5. Lilenbaum RC, Herbst RS. Vinorelbine and gemcitabine combinations in advanced non small-cell lung cancer. Clin Lung Cancer. 2000;2(2): 123-127.
6. ClinicalTrials.gov. Search terms: "vincristine OR vinblastine OR vinorelbine OR vindesine." Accessed December 6, 2015.
7. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100(1-2): 72-79.
8. Nutrition Business Journal. NBJ Supplement Business Report 2015. New York, NY: Penton Media, Inc; 2015.
9. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc. 2003;103(3): 323-328.
10. Dietary supplements market is expected to reach US $179.8 billion, globally in 2020: persistence market research. Globe Newswire. http://globenewswire.com/news-release/2015/04/23/727513/10130416/en/Dietary-Supplements-Market-is-Expected-to-Reach-US-179-8-Billion-Globally-in-2020-Persistence-Market-Research.html. Updated April 23, 2015. Accessed April 22, 2016.
11. Super foods. City of Hope. http://nationalevents.cityofhope.org/site/PageNavigator/walk_super_foods. Accessed April 22, 2016.
12. Google advanced searches of "(supplement)" in Interventions field and "cancer" in Conditions field in clinicaltrials.gov. Accessed November 15, 2015.
13. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014;6(222): 222ra18.
14. Piao BK, Wang YX, Xie GR, et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res. 2004;24(1): 303-309.
15. Paller CJ, Rudek MA, Zhou XC, et al. A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination. Prostate. 2015;75(14): 1518-1525.
16. Paller CJ, Ye X, Wozniak PJ, et al. A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis. 2013;16(1): 50-55.
17. Levine M, Padayatty SJ, Espey MG. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011;2(2): 78-88.
18. Association for Molecular Pathology v Myriad Genetics, Inc. US Supreme Court. 2013. http://www.uspto.gov/sites/default/files/patents/law/exam/myriad_20130613.pdf.
19. Hirshfeld AH. 2014 procedure for subject matter eligibility analysis of claims reciting or involving laws of nature/natural principles, natural phenomena, and/or natural products [memorandum]. United States Patent and Trademark Office. http://www.uspto.gov/patents/law/exam/myriad-mayo_guidance.pdf. March 4, 2014. Accessed April 22, 2016.
20. Food and Drug Administration. Botanical drug development: guidance for industry. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM458484.pdf. Updated August 2015. Accessed April 22, 2016.
21. Shabbir M, Love J, Montgomery B. Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer. Oncol Rep. 2008;19(3): 831-835.
22. Pfeifer BL, Pirani JF, Hamann SR, Klippel KF. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. BJU Int. 2000;85(4): 481-485.
23. Guns ES, Goldenberg SL, Brown PN. Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol. Can J Urol. 2002;9(6): 1684-1688.
24. Blumenthal M. The rise and fall of PC-SPES: new generation of herbal supplement, adulterated product, or new drug? Integr Cancer Ther. 2002;1(3): 266-270.
25. DiPaola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med. 1998;339(12): 785-791.
26. Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 2013;11: 222.
27. O’Connor A. New York attorney general targets supplements at major retailers. New York Times. http://well.blogs.nytimes.com/2015/02/03/new-york-attorney-general-targets-supplements-at-major-retailers/. February 3, 2015. Accessed April 22, 2016.
28. Generally recognized as safe (GRAS). U.S. Food and Drug Administration. http://www.fda.gov/food/ingredientspackaginglabeling/gras/default.htm. Accessed April 22, 2016.
29. Substances generally recognized as safe. U.S. Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=182.20. Revised April 1, 2015. Accessed April 22, 2016.
30. Wagner RC. Warning Letter. US Food and Drug Administration. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm202785.htm. February 23, 2010. Accessed April 22, 2016.
31. Guidance for industry: a food labeling guide (11. Appendix C: Health Claims). U.S. Food and Drug Administration. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064919.htm. Updated August 20, 2015. Accessed April 22, 2016.
32. Federal Trade Commission. Dietary supplements: an advertising guide for industry. https://www.ftc.gov/tips-advice/business-center/guidance/dietary-supplements-advertising-guide-industry. Published April 2001. Accessed April 22, 2016.
33. U.S. Government Accountability Office. http://www.gao.gov/products/GAO-09-250. Dietary supplements: FDA should take further actions to improve oversight and consumer understanding. Published January 29, 2009. Accessed April 22, 2016.
34. Marcus DM, Grollman AP. The consequences of ineffective regulation of dietary supplements. Arch Intern Med. 2012;172(13): 1035-1036.
35. Morris CA, Avorn J. Internet marketing of herbal products. JAMA. 2003;290(11): 1505-1509.
36. Wang MT, Gamble G, Bolland MJ, Grey A. Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. PLoS One. 2014;9(7): e101533.
37. Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006;12(13): 4018-4026.
38. Castle EP. Is it true that pomegranate juice may slow the growth of prostate cancer? How much should I drink? Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/prostate-cancer/expert-answers/pomegranate-juice/faq-20058204. Published May 4, 2013. Accessed April 22, 2016.
39. New study reveals four nutrients that lower PSA and slow cancer progression. Life Extension. http://www.lifeextension.com/protocols/cancer/prostate-cancer-prevention/page-06. Accessed April 22, 2016.
40. Paller CJ, Olatoye D, Xie S, et al. The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2014;17(1): 28-33.
41. Antonarakis ES, Chen Y, Elsamanoudi SI, et al. Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database. BJU Int. 2011;108(3): 378-385.
42. Scher HI, Halabi S, Tannock I, et al; Prostate Cancer Clinical Trials Working Group. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008;26(7): 1148-1159.
43. Chaston I. Entrepreneurial Marketing: Sustaining Growth in All Organisations. London, UK: Palgrave Macmillan; 2015.
44. Murr A. A winning equation. Newsweek. http://www.newsweek.com/winning-equation-108969. Published August 6, 2006.
45. FTC complaint charges deceptive advertising by POM Wonderful [press release]. Washington, DC: Federal Trade Commission; September 27, 2010. https://www.ftc.gov/news-events/press-releases/2010/09/ftc-complaint-charges-deceptive-advertising-pom-wonderful. Accessed May 3, 2016.
46. POMWonderful, LLC v Federal Trade Commission. US Court of Appeals. Argued May 2, 2014. https://www.ftc.gov/system/files/documents/cases/pom_dc_circuit1_0.pdf.
47. Pantuck AJ, Pettaway CA, Dreicer R, et al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015;18(3): 242-248.
48. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans’ views on the use and regulation of dietary supplements. Arch Intern Med. 2001;161(6): 805-810.
49. Marty AT. Alternative Medicine Natural Medicines Comprehensive Database. JAMA. 2000;283(22): 2992-2993.
50. Hall H. Diet supplements or nutritional supplements: a ruse by any other name is still a ruse. Science-Based Medicine blog. https://www.sciencebasedmedicine.org/diet-supplements-or-nutritional-supplements-a-ruse-by-any-other-name-is-still-a-ruse/ Posted February 22, 2011. Accessed May 3, 2016.